Werewolf Therapeutics, Inc. (HOWL)
1.07
+0.06
(+5.94%)
USD |
NASDAQ |
Dec 10, 16:00
1.07
0.00 (0.00%)
After-Hours: 16:36
Werewolf Therapeutics EPS Diluted (Quarterly): -0.3574 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Insmed, Inc. | -1.747 |
| Viking Therapeutics, Inc. | -0.8083 |
| ALX Oncology Holdings, Inc. | -0.4133 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.37M |
| Total Expenses (Quarterly) | 16.37M |
| Enterprise Value | 20.61M |
| Earnings Yield | -151.3% |
| Normalized Earnings Yield | -156.07 |